| 1 (225) | Banco Bilbao Vizcaya Argentaria, Spain | ESP |  |
| 2 (257) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 3 (290) | AstraZeneca, United Kingdom | GBR | |
| 4 (306) | Philips Research, Eindhoven | NLD | |
| 5 (332) | CaixaBank SA * | ESP | |
| 6 (340) | Sanofi, France | FRA | |
| 7 (396) | Janssen Research & Development, LLC | BEL | |
| 8 (445) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 9 (450) | Siemens AG, Germany | DEU | |
| 10 (456) | AstraZeneca, Sweden | SWE | |
| 11 (477) | Bayer AG, Germany | DEU | |
| 12 (496) | Novo Nordisk A/S | DNK | |
| 13 (510) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 14 (568) | Nestle Switzerland | CHE | |
| 15 (593) | UCB Pharma SA, UK | GBR | |
| 16 (668) | Siemens Healthineers, Germany | DEU | |
| 17 (686) | Merck KGaA, Germany | DEU | |
| 18 (691) | GlaxoSmithKline, United Kingdom | GBR | |
| 19 (791) | GlaxoSmithKline, Belgium | BEL | |
| 20 (820) | BMJ Group | GBR | |
| 21 (851) | IMEC International * | BEL | |
| 22 (958) | Novartis, Switzerland | CHE | |
| 23 (1023) | Frontiers Media SA | CHE | |
| 24 (1031) | Boehringer Ingelheim GmbH Germany | DEU | |
| 25 (1041) | Sanofi, Germany | DEU | |
| 26 (1084) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 27 (1176) | Bosch, Germany | DEU | |
| 28 (1303) | UCB Pharma SA, Belgium | BEL | |
| 29 (1491) | Pfizer Inc, Spain | ESP | |
| 30 (1532) | Pfizer Inc, United Kingdom | GBR | |
| 31 (1594) | BASF, Germany | DEU | |
| 32 (2993) | SINTEF Group * | NOR | |
| 33 (3964) | Grupo Jose de Mello * | PRT | |
| 34 (4460) | Ensino Lusofona * | PRT | |
|
